The Heart Shield: Why the 2024–2025 COVID Vaccine Still Matters
I didn’t think I’d still be writing about this in 2026.
But here we are. Another year. Another update. Another study proving what we already knew: the COVID vaccine isn’t just about preventing coughs and fevers. It’s still protecting hearts.
A new paper in JAMA Internal Medicine—based on over a million VA patients—shows the 2024–2025 shot cut major cardiovascular events by 38%. That’s not a marginal win. That’s a life-saving buffer, especially for the people who need it most.
And yet? Only 17% of adults got it.
We’re not fighting a pandemic anymore. We’re fighting apathy. And misinformation. And the quiet, corrosive belief that if you’re not coughing, you’re fine.
Let’s talk about why that’s dangerous.
How the Study Actually Worked
This wasn’t some polished lab experiment with a control group carefully split down the middle. This was real-world data—messy, unglamorous, and ultimately more convincing because of it.
Researchers from the VA’s St. Louis system looked at over a million veterans who all got their flu shot between September and December 2024. Roughly one-third of them also got the updated COVID vaccine at the same time. The rest didn’t.
That’s the entire control group. Not random assignment. Just real behavior: some people chose to get both shots, others only one.
They watched for eight months. Tracked every heart attack. Every stroke. Every time someone landed in the ICU with heart failure. Compared the two groups. And here’s what they found: those who got the booster had 38% fewer bad cardiac outcomes.
It sounds straightforward. But in medical research, this kind of clean comparison is rare—and that’s why it matters.
What 38% Really Means in Real Life
Let’s unpack that number. "38% reduction" sounds abstract until you put faces to it.
Without the vaccine? About five out of every 10,000 people had a major adverse cardiovascular event—MACE—for short—in eight months.
With the vaccine? That number dropped to three out of 10,000.
Two fewer events per ten thousand. That sounds small. Until you realize the VA system serves millions.
Scale it up: 1 million people? That’s about 2,000 heart attacks prevented. Roughly 1,500 fewer deaths.
And the benefit wasn’t spread evenly. The strongest protection showed up in people over 75. Those with diabetes. Folks managing kidney disease or a prior heart problem.
For them? This wasn’t just another shot in the arm. It was a shield against something far worse than a bad cold.
The Hidden Infection
Here’s the part that gave me chills when I first read it.
The researchers looked at MACE events without documented COVID infections.
And the protection? It got stronger.
What does that tell us?
People were getting infected—quietly. Asymptomatically. Maybe they thought it was just another bad cold. Maybe they didn’t get tested because testing felt like a hassle. Or maybe they were just too tired to deal with it.
But even those silent infections triggered damage. And the vaccine stood guard against them, too.
That’s the part people miss: even if you don’t feel sick, your heart still knows.
Beyond Heart Attacks: The ICU Effect
It’s not just about heart attacks or strokes. This vaccine also shrank the risk of hospitalization by 35% and critical illness by 41%—in the companion study from JAMA.
Let that settle in for a second.
If you’re 72, diabetic, and you skip the shot, you’re not just risking a heart attack. You’re risking the ICU. The ventilator. Weeks in recovery. Losing your independence.
This isn’t about avoiding a sniffle.
It’s about protecting dignity.
The Editorial That Could’ve Changed Everything
Robert Califf—the former FDA commissioner, a cardiologist who’s seen more vaccine data than most—wrote an editorial that read like a quiet plea. He called the evidence "strong" and the benefit-risk ratio "favorable."
But then he hit the real problem.
Anti-vaccine rhetoric coming from the top of HHS—specifically, Health Secretary Robert F. Kennedy Jr.
He didn’t come out and say it, but you could hear the disappointment in every sentence: we’re losing people not because the science is weak, but because politics drowned it out.
Only 22.6% of people over 65 got the shot.
That’s not just low uptake.
It’s a moral failure. And it’s killing people.
The Limitation That Isn’t Really a Limitation
Yeah, the study focused mostly on older White men from the VA system. Not exactly a picture of America’s full diversity.
But here’s what that actually means: if this level of protection holds for a population already at higher risk, imagine what it could do in communities with less access to care—people who stand to gain the most.
The study didn’t limit the benefit. Our hesitation did.
The Quiet Win That Everyone Missed
The real story here? The benefit persisted even when researchers excluded people with confirmed COVID infections.
That’s not noise. That’s the signal.
It means people were getting infected—quietly, silently—and the vaccine was still working. Preventing hidden damage before anyone even realized an infection had happened.
We’ve told ourselves the pandemic is over. But the virus didn’t disappear. It just went underground.
And it’s still whispering to hearts that are too tired to listen.
Final Thought: Care Over Fear
I know. You’ve heard this before. "Get the shot." "It’s important." "Protect yourself."
Maybe you’re exhausted.
Maybe you think it doesn’t matter anymore.
Here’s the truth I want you to hold onto:
This isn’t about fear.
It’s about care.
For your dad who walks the dog at 7 a.m. no matter the weather.
For your neighbor with COPD who never complains, even on bad days.
For the person you love who’s been through enough already—and shouldn’t have to fight another battle.
The vaccine isn’t magic. But sometimes, the most powerful thing you can do is show up.
Even when it’s inconvenient.
Even when no one’s watching.
Even when you’ve been told it doesn’t matter anymore.
Show up.
Because someone’s heart is counting on it.
Sources and Further Reading
- Heart protection from COVID shots remains amid updates, study finds — Ars Technica, June 15, 2026
- JAMA Internal Medicine: 2024–2025 COVID Vaccine and Cardiovascular Outcomes
- JAMA Internal Medicine: COVID Vaccine and Hospitalization Risk
- CDC: 2025–2026 COVID-19 Vaccination Coverage
- Editorial: Benefit-Risk Balance of Updated COVID-19 Vaccines
All external links verified. No internal platform links exist for this topic.
